Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with long-acting synthetic
adrenocorticotropic hormone is in the treatment of patients with idiopathic membranous
nephropathy and high for renal failure.